PAVmed Inc
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
PAVM$1.56-4.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity (Deficit)
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
for the YEAR ENDED December 31, 2023
| PAVmed Inc. Stockholders’ Equity (Deficit) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred Stock · Common Stock · Additional Paid-In · Accumulated · Treasury · Non controlling | |||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Stock | Interest | Total | |
| Balance - December 31, 2022 | 1,205,759 | $2,695 | 6,300,703 | $6 | $216,195 | $(228,169) | $(408) | $20,615 | $10,934 |
| Dividends declared - Series B Convertible Preferred Stock | 99,454 | 298 | — | — | — | (298) | — | — | — |
| Issue common stock - PAVM ATM Facility | — | — | 321,288 | 1 | 1,823 | — | — | — | 1,824 |
| Vest - restricted stock awards | — | — | 6,666 | — | — | — | — | — | — |
| Conversions - Senior Secured Convertible Note | — | — | 1,745,824 | 2 | 10,000 | — | — | — | 10,002 |
| Conversions - majority-owned subsidiary common stock - Senior Secured Convertible Note | — | — | — | — | — | — | — | 167 | 167 |
| Purchase - Employee Stock Purchase Plan | — | — | 45,893 | — | 198 | — | 60 | — | 258 |
| Purchase - majority-owned subsidiary common stock - Employee Stock Purchase Plan | — | — | — | — | — | — | — | 551 | 551 |
| Issuance - majority-owned subsidiary common stock - At-The-Market Facility, net of financing charges | — | — | — | — | — | — | — | 284 | 284 |
| Impact of subsidiary equity transactions | — | — | — | — | 1,983 | — | — | (1,983) | — |
| Issuance - majority-owned subsidiary common stock - Settlement APA-RDx - Termination Payment | — | — | — | — | — | — | — | 713 | 713 |
| Issuance - vendor service agreement | — | — | 100,000 | — | 601 | — | — | 147 | 748 |
| Issuance - majority-owned subsidiary preferred stock | — | — | — | — | — | — | — | 18,625 | 18,625 |
| Issuance of shares related to reverse stock split | — | — | 45,541 | — | — | — | — | — | — |
| Incremental value from Z Warrant modification | — | — | — | — | 1,791 | (1,791) | — | — | — |
| Stock-based compensation - PAVmed Inc. | — | — | — | — | 4,255 | — | — | — | 4,255 |
| Stock-based compensation - majority-owned subsidiaries | — | — | — | — | 1,102 | — | — | 5,782 | 6,884 |
| Treasury stock | — | — | 12,590 | — | (348) | — | 348 | — | — |
| Net loss | — | — | — | — | — | (64,175) | — | (15,088) | (79,263) |
| Balance - December 31, 2023 | 1,305,213 | $2,993 | 8,578,505 | $9 | $237,600 | $(294,433) | $— | $29,813 | $(24,018) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.